Show simple item record

dc.creatorAleksić, Ema
dc.creatorMiljković-Selimović, Biljana
dc.creatorTambur, Zoran
dc.creatorAleksić, Nikola
dc.creatorBiočanin, Vladimir
dc.creatorAvramov, Stevan
dc.date.accessioned2022-01-21T13:14:47Z
dc.date.available2022-01-21T13:14:47Z
dc.date.issued2021
dc.identifier.issn2296-858X
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fmed.2021.763434/full
dc.identifier.urihttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8632019
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/4743
dc.description.abstractCampylobacter jejuni (C. jejuni) is one of the most frequent causes of bacterial enterocolitis globally. The disease in human is usually self-limiting, but when complications arise antibiotic therapy is required at a time when resistance to antibiotics is increasing worldwide. Mechanisms of antibiotic resistance in bacteria are diverse depending on antibiotic type and usage and include: enzymatic destruction or drug inactivation; alteration of the target enzyme; alteration of cell membrane permeability; alteration of ribosome structure and alteration of the metabolic pathway(s). Resistance of Campylobacter spp. to antibiotics, especially fluoroquinolones is now a major public health problem in developed and developing countries. In this review the mechanisms of resistance to fluoroquinolones, macrolides, tetracycline, aminoglycoside and the role of integrons in resistance of Campylobacter (especially at the molecular level) are discussed, as well as the mechanisms of resistance to β-lactam antibiotics, sulphonamides and trimethoprim. Multiple drug resistance is an increasing problem for treatment of campylobacter infections and emergence of resistant strains and resistance are important One Health issues.
dc.publisherLausanne: Frontiers Media S.A.
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFrontiers in Medicine
dc.subjectAntibiotic resistance
dc.subjectBacterial enterocolitis
dc.subjectCampylobacter
dc.subjectCechanisms of resistance
dc.subjectSignificance of resistant strains
dc.titleResistance to Antibiotics in Thermophilic Campylobacters.
dc.typearticleen
dc.rights.licenseBY
dc.rights.holder© 2021 Aleksić, Miljković-Selimović, Tambur, Aleksić, Biočanin and Avramov.
dc.citation.volume8
dc.identifier.doi10.3389/fmed.2021.763434
dc.identifier.pmid34859016
dc.identifier.scopus2-s2.0-85120706857
dc.identifier.wos000733892300001
dc.citation.apaAleksić, E., Miljković-Selimović, B., Tambur, Z., Aleksić, N., Biočanin, V., & Avramov, S. (2021). Resistance to Antibiotics in Thermophilic Campylobacters. Frontiers in Medicine, 8, 763434.
dc.citation.vancouverAleksić E, Miljković-Selimović B, Tambur Z, Aleksić N, Biočanin V, Avramov S. Resistance to Antibiotics in Thermophilic Campylobacters. Front Med. 2021;8:763434.
dc.citation.spage763434
dc.type.versionpublishedVersion
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/9816/fmed-08-763434.pdf
dc.citation.rankM21


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record